Elevated mean platelet volume is associated with impaired coronary microvascular function in patients with idiopathic dilated cardiomyopathy

Platelets

Volumn 23, Issue 3, 2012, Pages 177-183

  Erdogan, Dogan ^a   Tayyar, Senol ^a   Icli, Atilla ^a   Uysal, Bayram Ali ^a   Varol, Ercan ^a   Ozaydin, Mehmet ^a   Dogan, Abdullah ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Coronary flow reserve; Dilated cardiomyopathy; Mean platelet volume; Platelet activity

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY FLOW RESERVE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; MEAN PLATELET VOLUME; MICROVASCULATURE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT;

ADULT; AGED; BLOOD PLATELETS; CARDIOMYOPATHY, DILATED; CORONARY CIRCULATION; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MICROVESSELS; MIDDLE AGED; MYOCARDIUM; VENTRICULAR DYSFUNCTION, LEFT;

MOROCCAN PEPPER VIRUS;

EID: 84859750973     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.611273     Document Type: Article

References (32)

1. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Yamaguchi H, Kakoi H, Takabatake Y. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy. Am Heart J. 1994;127:376-381.
2. Erdogan D, Gullu H, Caliskan M, Ciftci O, Baycan S, Yildirir A, Muderrisoglu H. Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy. Heart. 2007;93:319-324.
3. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, Gallopin M, Salvadori P, Sorace O, Carpeggiani C, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002;105:186-193.
4. Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H, Muderrisoglu H. Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation. 2007;115:593-599.
5. Caiati C, Zedda N, Montaldo C, Montischi R, Iliceto S. Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: A noninvasive, rapid and effective method for coronary flow reserve assessment. J Am Coll Cardiol. 1999;34:122-130.
6. Saraste M, Koskenvuo J, Knuuti J, Toikka J, Laine H, Niemi P, Sakuma H, Hartiala J. Coronary flow reserve: Measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol. 2001;21:114-122.
7. Lip GYH, Gibbs CR. Does heart failure confer a hypercoagulable state? J Am Coll Cardiol. 1999;33:1424-1426.
8. Chung I, Lip GYH. Platelets and heart failure. Eur Heart J. 2006;27:2623-2631.
9. Jafri SM, Ozawz T, Mammen E, Levine TB, Johnson C, Goldstein S. Platelet function, thrombin and Ebrinolytic activity in patients with heart failure. Eur Heart J. 1993;14:205-212.
10. Erne P, Wardle J, Sanders K, Lewis SM, Maseri A. Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure. Thromb Haemost. 1988;59:259-263.
11. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: Is there a practical index of platelet activity? Clin Appl Thromb Hemost. 2003;9:177-190.
12. Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets. 2002;13:301-306.
13. Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996;7:157-161.
14. D'Erasmo E, Aliberti G, Celi FS, Romagnoli E, Vecci E, Mazzuoli GF. Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction. J Intern Med. 1990;227:11-14.
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
16. Jagroop IA, Tsiara S, Mikhailidis DP. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets. 2003;14:335-336.
17. Kamath S, Blann AD, Lip GY. Platelet activation: Assessment and quantification. Eur Heart J. 2001;22:1561-1571.
18. Karpatkin S, Khan Q, Freedman M. Heterogeneity of platelet function. Correlation with platelet volume. Am J Med. 1978;64:542-546.
19. Jakubowski JA, Adler B, Thompson CB, Valeri CR, Deykin D. Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. J Lab Clin Med. 1985;105:271-276.
20. Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract. 2009;63:1509-1515.
21. Serebruany V, McKenzie M, Meister A, Fuzaylov S, Gurbel P, Atar D, Gattis W, O'Connor C. Whole blood impedence aggregometry for the assessment of platelet function in patients with congestive heart failure (EPCOT Trial). Eur J Heart Fail. 2002;4:461-467.
22. Serebruany VL, Murugesan SR, Pothula A, Atar D, Lowry DR, O'Connor CM, Gurbel PA. Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy. Eur J Heart Fail. 1999;1:243-249.
23. Gurbel PA, Gattis WA, Fuzaylov SF, Gaulden L, Hasselblad V, Serebruany VL, O'Connor CM. Evaluation of platelets in heart failure: Is platelet severity related to etiology, functional class, or clinical outcomes? Am Heart J. 2002;143:1068-1075.
24. O'Connor CM, Gurbel PA, Serebruany VL. Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure. Am J Cardiol. 1999;83:1345-1349.
25. Ueland T, Aukrust P, Yndestad A, Otterdal K, Froland SS, Dickstein K, Kjekshus J, Gullestad L, Damas JK. Soluble CD40 ligand in acute and chronic heart failure. Eur Heart J. 2005;26:1101-1107.
26. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Yamanaka T, Kakoi H, Takabatake Y. Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J. 1993;125:93-98.
27. van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, Blanksma PK, Siebelink HM, Vaalburg WM, van Gilst WH, Crijns HJ. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2000;35:19-28.
28. Nitenberg A, Foult JM, Blanchet F, Zouioueche S. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. Am J Cardiol. 1985;55:748-754.
29. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
30. Santagata P, Rigo F, Gherardi S, Pratali L, Drozdz J, Varga A, Picano E. Clinical and functional determinants of coronary Fow reserve in non-ischemic dilated cardiomyopathy: An echocardiographic study. Int J Cardiol. 2005;105:46-52.
31. Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG, Terrovitis JV, Ntalianis A, Nanas JN. Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2008;52:1391-1398.
32. Sezer M, Okcular I, Goren T, Oflaz H, Nisanci Y, Umman B, Mercanoglu F, Bilge AK, Meric M, Umman S. Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2007;93:313-318.